Start your engineering — CARs take to the TRAC – Nature.com
|
Start your engineering — CARs take to the TRAC
Nature.com T cells genetically engineered to express chimeric antigen receptors (CARs) that recognize tumour-associated antigens are promising anticancer agents. In particular, anti-CD19 CAR T cells can induce complete remission in patients with B-cell malignancies. |
